In neutral lipid storage disease patients, the presence of CGI-58 mutation is more strongly associated with the potential development of fatty liver disease and hepatomegaly than the ATGL mutation (Lord and Brown, 2012), which indicates that CGI-58 has an independent function of ATGL in the liver. This evidence concerns the gene PNPLA2 and Lipid storage disease.